Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2474
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept ; volume:17 ; number:1 ; day:26 ; month:5 ; year:2016 ; pages:1-10 ; date:12.2016
BMC musculoskeletal disorders ; 17, Heft 1 (26.5.2016), 1-10, 12.2016
- Urheber
-
Alten, Rieke
- Beteiligte Personen und Organisationen
-
Bingham, Clifton O.
Cohen, Stanley B.
Curtis, Jeffrey R.
Kelly, Sheila
Wong, Dennis
Genovese, Mark C.
SpringerLink (Online service)
- DOI
-
10.1186/s12891-016-1082-z
- URN
-
urn:nbn:de:1111-20160528327
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Alten, Rieke
- Bingham, Clifton O.
- Cohen, Stanley B.
- Curtis, Jeffrey R.
- Kelly, Sheila
- Wong, Dennis
- Genovese, Mark C.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus
Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients
Vaccination in Patients with Rheumatoid Arthritis Receiving Immunotherapies
Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients
Correction to: Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients
Serologic response to pneumococcal vaccination in children experiencing recurrent invasive pneumococcal disease
Pneumococcal vaccination in children with underlying conditions
Monocyte-derived transcriptomes explain the ineffectiveness of abatacept in rheumatoid arthritis
Impact of pneumococcal conjugate vaccination on the epidemiology of pneumococcal disease in Germany
Impact of national pneumococcal vaccination program on invasive pneumococcal diseases in South Korea
Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry
Effect of heptavalent pneumococcal conjugate vaccination on invasive pneumococcal disease in preterm born infants
Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus
Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients
Vaccination in Patients with Rheumatoid Arthritis Receiving Immunotherapies
Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients
Correction to: Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients
Serologic response to pneumococcal vaccination in children experiencing recurrent invasive pneumococcal disease
Pneumococcal vaccination in children with underlying conditions
Monocyte-derived transcriptomes explain the ineffectiveness of abatacept in rheumatoid arthritis
Impact of pneumococcal conjugate vaccination on the epidemiology of pneumococcal disease in Germany
Impact of national pneumococcal vaccination program on invasive pneumococcal diseases in South Korea
Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry
Effect of heptavalent pneumococcal conjugate vaccination on invasive pneumococcal disease in preterm born infants
Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus
Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients
Vaccination in Patients with Rheumatoid Arthritis Receiving Immunotherapies
Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients
Correction to: Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients
Serologic response to pneumococcal vaccination in children experiencing recurrent invasive pneumococcal disease
Pneumococcal vaccination in children with underlying conditions
Monocyte-derived transcriptomes explain the ineffectiveness of abatacept in rheumatoid arthritis
Impact of pneumococcal conjugate vaccination on the epidemiology of pneumococcal disease in Germany
Impact of national pneumococcal vaccination program on invasive pneumococcal diseases in South Korea
Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry